Management of patients with biliary sphincter of Oddi disorder without sphincter of Oddi manometry

Evangelos Kalaitzakis, Tim Ambrose, Jane Phillips-Hughes, Jane Collier, Roger W Chapman, Evangelos Kalaitzakis, Tim Ambrose, Jane Phillips-Hughes, Jane Collier, Roger W Chapman

Abstract

Background: The paucity of controlled data for the treatment of most biliary sphincter of Oddi disorder (SOD) types and the incomplete response to therapy seen in clinical practice and several trials has generated controversy as to the best course of management of these patients. In this observational study we aimed to assess the outcome of patients with biliary SOD managed without sphincter of Oddi manometry.

Methods: Fifty-nine patients with biliary SOD (14% type I, 51% type II, 35% type III) were prospectively enrolled. All patients with a dilated common bile duct were offered endoscopic retrograde cholangiopancreatography (ERCP) and sphincterotomy whereas all others were offered medical treatment alone. Patients were followed up for a median of 15 months and were assessed clinically for response to treatment.

Results: At follow-up 15.3% of patients reported complete symptom resolution, 59.3% improvement, 22% unchanged symptoms, and 3.4% deterioration. Fifty-one percent experienced symptom resolution/improvement on medical treatment only, 12% after sphincterotomy, and 10% after both medical treatment/sphincterotomy. Twenty percent experienced at least one recurrence of symptoms after initial response to medical and/or endoscopic treatment. Fifty ERCP procedures were performed in 24 patients with an 18% complication rate (16% post-ERCP pancreatitis). The majority of complications occurred in the first ERCP these patients had. Most complications were mild and treated conservatively. Age, gender, comorbidity, SOD type, dilated common bile duct, presence of intact gallbladder, or opiate use were not related to the effect of treatment at the end of follow-up (p > 0.05 for all).

Conclusions: Patients with biliary SOD may be managed with a combination of endoscopic sphincterotomy (performed in those with dilated common bile duct) and medical therapy without manometry. The results of this approach with regards to symptomatic relief and ERCP complication rate are comparable to those previously published in the literature in cohorts of patients assessed by manometry.

Figures

Figure 1
Figure 1
Flow chart of the management of the current cohort of patients with a clinical diagnosis of SOD (n = 59)

References

    1. Bozkurt T, Orth KH, Butsch B, Lux G. Long-term clinical outcome of post-cholecystectomy patients with biliary-type pain: results of manometry, non-invasive techniques and endoscopic sphincterotomy. Eur J Gastroenterol Hepatol. 1996;8(3):245–249. doi: 10.1097/00042737-199603000-00011.
    1. Linder JD, Klapow JC, Linder SD, Wilcox CM. Incomplete response to endoscopic sphincterotomy in patients with sphincter of Oddi dysfunction: evidence for a chronic pain disorder. Am J Gastroenterol. 2003;98(8):1738–1743. doi: 10.1111/j.1572-0241.2003.07597.x.
    1. Freeman ML, Gill M, Overby C, Cen YY. Predictors of outcomes after biliary and pancreatic sphincterotomy for sphincter of oddi dysfunction. J Clin Gastroenterol. 2007;41(1):94–102. doi: 10.1097/01.mcg.0000225584.40212.fb.
    1. Petersen BT. An evidence-based review of sphincter of Oddi dysfunction: part I, presentations with "objective" biliary findings (types I and II) Gastrointest Endosc. 2004;59(4):525–534. doi: 10.1016/S0016-5107(04)00012-4.
    1. Behar J, Corazziari E, Guelrud M, Hogan W, Sherman S, Toouli J. Functional gallbladder and sphincter of oddi disorders. Gastroenterology. 2006;130(5):1498–1509. doi: 10.1053/j.gastro.2005.11.063.
    1. Thatcher BS, Sivak MV Jr, Tedesco FJ, Vennes JA, Hutton SW, Achkar EA. Endoscopic sphincterotomy for suspected dysfunction of the sphincter of Oddi. Gastrointest Endosc. 1987;33(2):91–95. doi: 10.1016/S0016-5107(87)71517-X.
    1. Viceconte G, Micheletti A. Endoscopic manometry of the sphincter of Oddi: its usefulness for the diagnosis and treatment of benign papillary stenosis. Scand J Gastroenterol. 1995;30(8):797–803. doi: 10.3109/00365529509096330.
    1. Cicala M, Habib FI, Vavassori P, Pallotta N, Schillaci O, Costamagna G, Guarino MP, Scopinaro F, Fiocca F, Torsoli A. et al.Outcome of endoscopic sphincterotomy in post cholecystectomy patients with sphincter of Oddi dysfunction as predicted by manometry and quantitative choledochoscintigraphy. Gut. 2002;50(5):665–668. doi: 10.1136/gut.50.5.665.
    1. Sherman S, Ruffolo TA, Hawes RH, Lehman GA. Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts. Gastroenterology. 1991;101(4):1068–1075.
    1. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, Moore JP, Fennerty MB, Ryan ME, Shaw MJ. et al.Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335(13):909–918. doi: 10.1056/NEJM199609263351301.
    1. Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, Overby CS, Aas J, Ryan ME, Bochna GS. et al.Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54(4):425–434. doi: 10.1067/mge.2001.117550.
    1. Corazziari E, Shaffer EA, Hogan WJ, Sherman S, Toouli J. Functional disorders of the biliary tract and pancreas. Gut. 1999;45(Suppl 2):II48–54. doi: 10.1136/gut.45.2008.ii48.
    1. Khuroo MS, Zargar SA, Yattoo GN. Efficacy of nifedipine therapy in patients with sphincter of Oddi dysfunction: a prospective, double-blind, randomized, placebo-controlled, cross over trial. Br J Clin Pharmacol. 1992;33(5):477–485.
    1. Rolny P, Geenen JE, Hogan WJ. Post-cholecystectomy patients with "objective signs" of partial bile outflow obstruction: clinical characteristics, sphincter of Oddi manometry findings, and results of therapy. Gastrointest Endosc. 1993;39(6):778–781. doi: 10.1016/S0016-5107(93)70264-3.
    1. Geenen JE, Hogan WJ, Dodds WJ, Toouli J, Venu RP. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction. N Engl J Med. 1989;320(2):82–87. doi: 10.1056/NEJM198901123200203.
    1. Toouli J, Roberts-Thomson IC, Kellow J, Dowsett J, Saccone GT, Evans P, Jeans P, Cox M, Anderson P, Worthley C. et al.Manometry based randomised trial of endoscopic sphincterotomy for sphincter of Oddi dysfunction. Gut. 2000;46(1):98–102. doi: 10.1136/gut.46.1.98.
    1. Varadarajulu S, Hawes RH, Cotton PB. Determination of sphincter of Oddi dysfunction in patients with prior normal manometry. Gastrointest Endosc. 2003;58(3):341–344. doi: 10.1067/S0016-5107(03)00005-1.
    1. Thune A, Scicchitano J, Roberts-Thomson I, Toouli J. Reproducibility of endoscopic sphincter of Oddi manometry. Dig Dis Sci. 1991;36(10):1401–1405. doi: 10.1007/BF01296806.
    1. Arguedas MR, Linder JD, Wilcox CM. Suspected sphincter of Oddi dysfunction type II: empirical biliary sphincterotomy or manometry-guided therapy? Endoscopy. 2004;36(2):174–178. doi: 10.1055/s-2004-814186.
    1. Botoman VA, Kozarek RA, Novell LA, Patterson DJ, Ball TJ, Wechter DG, Neal LA. Long-term outcome after endoscopic sphincterotomy in patients with biliary colic and suspected sphincter of Oddi dysfunction. Gastrointest Endosc. 1994;40(2 Pt 1):165–170. doi: 10.1016/S0016-5107(94)70160-1.
    1. Wehrmann T, Wiemer K, Lembcke B, Caspary WF, Jung M. Do patients with sphincter of Oddi dysfunction benefit from endoscopic sphincterotomy? A 5-year prospective trial. Eur J Gastroenterol Hepatol. 1996;8(3):251–256. doi: 10.1097/00042737-199603000-00012.
    1. Vitton V, Delpy R, Gasmi M, Lesavre N, Abou-Berdugo E, Desjeux A, Grimaud JC, Barthet M. Is endoscopic sphincterotomy avoidable in patients with sphincter of Oddi dysfunction? Eur J Gastroenterol Hepatol. 2008;20(1):15–21. doi: 10.1097/MEG.0b013e3282eeb4a1.
    1. Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PD, Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology. 1998;115(6):1518–1524. doi: 10.1016/S0016-5085(98)70031-9.
    1. Saad AM, Fogel EL, McHenry L, Watkins JL, Sherman S, Lazzell-Pannell L, Lehman GA. Pancreatic duct stent placement prevents post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction but normal manometry results. Gastrointest Endosc. 2008;67(2):255–261. doi: 10.1016/j.gie.2007.06.022.
    1. Desautels SG, Slivka A, Hutson WR, Chun A, Mitrani C, DiLorenzo C, Wald A. Postcholecystectomy pain syndrome: pathophysiology of abdominal pain in sphincter of Oddi type III. Gastroenterology. 1999;116(4):900–905. doi: 10.1016/S0016-5085(99)70073-9.
    1. Choudhry U, Ruffolo T, Jamidar P, Hawes R, Lehman G. Sphincter of Oddi dysfunction in patients with intact gallbladder: therapeutic response to endoscopic sphincterotomy. Gastrointest Endosc. 1993;39(4):492–495. doi: 10.1016/S0016-5107(93)70157-1.
    1. Ruffolo TA, Sherman S, Lehman GA, Hawes RH. Gallbladder ejection fraction and its relationship to sphincter of Oddi dysfunction. Dig Dis Sci. 1994;39(2):289–292. doi: 10.1007/BF02090199.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner